IL6R and infection: Because strategies with neutralizing Ab targeting a signaling pathway might exhibit off-target effects, future discoveries of a small peptide targeting the eCIRP–IL-6R interaction could be helpful to counter eCIRP-induced immune tolerance in macrophages to safeguard patients from secondary infection.